Commonground
Senior Moderator
Jan 13, 2025
NYC Health + Hospitals/Bellevue today announced it will receive $2 million from the federal government to enhance national avian influenza preparedness, one of only thirteen institutions nationwide to receive this funding. Bellevue Hospital is the designated Regional Emerging Special Pathogen Treatment Center (RESPTC) for Region 2, leading special pathogen preparedness and response efforts in New York, New Jersey, Puerto Rico, and the U.S. Virgin Islands. The funding announcement is timely and critical, with the recent development of the first H5N1-related human death in the U.S. The funding is part of a comprehensive $306 million investment by the U.S. Department of Health and Human Services (HHS) as part of the nation’s H5N1 Avian Flu response. H5N1 is a highly pathogenic avian influenza virus that is widespread among wild birds globally and has been responsible for outbreaks in poultry and dairy cows. While the risk to the U.S. general population remains low, the virus has a historical fatality rate of over 50%. The risk of H5N1 coming to New York City is low.
Today’s announcement builds on the ongoing H5N1 preparedness activities at NYC Health + Hospitals, including the H5N1 training exercise held by the health system and the NYC Health Department in October.
Continued: https://www.nychealthandhospitals.o...al-funding-to-advance-avian-flu-preparedness/
NYC Health + Hospitals/Bellevue today announced it will receive $2 million from the federal government to enhance national avian influenza preparedness, one of only thirteen institutions nationwide to receive this funding. Bellevue Hospital is the designated Regional Emerging Special Pathogen Treatment Center (RESPTC) for Region 2, leading special pathogen preparedness and response efforts in New York, New Jersey, Puerto Rico, and the U.S. Virgin Islands. The funding announcement is timely and critical, with the recent development of the first H5N1-related human death in the U.S. The funding is part of a comprehensive $306 million investment by the U.S. Department of Health and Human Services (HHS) as part of the nation’s H5N1 Avian Flu response. H5N1 is a highly pathogenic avian influenza virus that is widespread among wild birds globally and has been responsible for outbreaks in poultry and dairy cows. While the risk to the U.S. general population remains low, the virus has a historical fatality rate of over 50%. The risk of H5N1 coming to New York City is low.
Today’s announcement builds on the ongoing H5N1 preparedness activities at NYC Health + Hospitals, including the H5N1 training exercise held by the health system and the NYC Health Department in October.
Continued: https://www.nychealthandhospitals.o...al-funding-to-advance-avian-flu-preparedness/